Total Payments
$101,516
2024 Payments
$2,103
Companies
48
Transactions
932
Medicare Patients
3,863
Medicare Billing
$358,581
Payment Breakdown by Category
Other$58,204 (57.3%)
Consulting$22,980 (22.6%)
Food & Beverage$16,659 (16.4%)
Travel$3,632 (3.6%)
Education$40.35 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,954 | 17 | 34.4% |
| Honoraria | $23,250 | 4 | 22.9% |
| Consulting Fee | $22,980 | 12 | 22.6% |
| Food and Beverage | $16,659 | 886 | 16.4% |
| Travel and Lodging | $3,632 | 9 | 3.6% |
| Education | $40.35 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $40,769 | 113 | $0 (2024) |
| Aqua Pharmaceuticals | $25,411 | 42 | $0 (2017) |
| Allergan, Inc. | $18,206 | 85 | $0 (2022) |
| Verrica Pharmaceuticals Inc. | $4,353 | 6 | $0 (2023) |
| ABBVIE INC. | $2,005 | 131 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,747 | 94 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,107 | 83 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $811.83 | 8 | $0 (2021) |
| Janssen Biotech, Inc. | $677.30 | 37 | $0 (2024) |
| Amgen Inc. | $592.04 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,103 | 135 | ABBVIE INC. ($385.01) |
| 2023 | $6,194 | 109 | Verrica Pharmaceuticals Inc. ($4,353) |
| 2022 | $6,361 | 90 | Allergan, Inc. ($4,718) |
| 2021 | $4,938 | 89 | PFIZER INC. ($3,497) |
| 2020 | $2,277 | 78 | PFIZER INC. ($1,024) |
| 2019 | $12,856 | 158 | PFIZER INC. ($10,882) |
| 2018 | $26,882 | 143 | PFIZER INC. ($16,412) |
| 2017 | $39,904 | 130 | Aqua Pharmaceuticals ($25,411) |
All Payment Transactions
932 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.29 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.95 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.41 | General |
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Immunology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.61 | General |
| Category: Immunology | ||||||
| 11/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.82 | General |
| Category: Immunology | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,032 | 2,250 | $279,147 | $97,056 |
| 2022 | 9 | 913 | 1,888 | $244,641 | $85,639 |
| 2021 | 10 | 953 | 2,241 | $266,103 | $95,852 |
| 2020 | 9 | 965 | 2,062 | $223,927 | $80,033 |
Total Patients
3,863
Total Services
8,441
Medicare Billing
$358,581
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 418 | $101,252 | $35,375 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 215 | $36,698 | $12,940 | 35.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 133 | 172 | $33,855 | $11,250 | 33.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 178 | 274 | $34,099 | $9,806 | 28.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 87 | 116 | $24,925 | $9,521 | 38.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 33 | 51 | $15,946 | $6,258 | 39.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 131 | 875 | $10,754 | $4,316 | 40.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 46 | 91 | $9,093 | $3,536 | 38.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 26 | $8,765 | $2,867 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,760 | $1,187 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 237 | 441 | $106,823 | $38,281 | 35.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 94 | 121 | $25,999 | $9,931 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 160 | $27,310 | $9,485 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 164 | 252 | $31,361 | $9,252 | 29.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 105 | 142 | $27,950 | $9,062 | 32.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 116 | 676 | $8,308 | $3,300 | 39.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 17 | 25 | $7,817 | $3,085 | 39.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 33 | 53 | $5,296 | $2,141 | 40.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,776 | $1,103 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 264 | 515 | $120,469 | $44,322 | 36.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 94 | 126 | $26,582 | $10,502 | 39.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 162 | 270 | $33,335 | $9,882 | 29.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 102 | 140 | $27,270 | $9,226 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 158 | $25,852 | $9,005 | 34.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 123 | 925 | $10,874 | $4,602 | 42.3% |
About Dr. Sherry Ingraham, MD
Dr. Sherry Ingraham, MD is a Dermatology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700852605.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sherry Ingraham, MD has received a total of $101,516 in payments from pharmaceutical and medical device companies, with $2,103 received in 2024. These payments were reported across 932 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,954).
As a Medicare-enrolled provider, Ingraham has provided services to 3,863 Medicare beneficiaries, totaling 8,441 services with total Medicare billing of $358,581. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Houston, TX
- Active Since 02/28/2006
- Last Updated 06/25/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1700852605
Products in Payments
- EUCRISA (Drug) $40,600
- YCANTH (Drug) $4,353
- COSENTYX (Biological) $1,183
- SKYRIZI (Biological) $609.74
- Acticlate (Drug) $548.55
- Sotyktu (Drug) $511.85
- DUPIXENT (Biological) $419.20
- VTAMA (Drug) $397.49
- TALTZ (Drug) $378.04
- Humira (Biological) $364.45
- Genadur (Drug) $350.00
- Neo-Synalar Cream (Drug) $350.00
- RINVOQ (Biological) $346.99
- REMICADE (Biological) $327.45
- Otezla (Drug) $319.56
- COSENTYX (Drug) $263.59
- Enbrel (Biological) $258.73
- Tolak (Drug) $246.25
- Tremfya (Drug) $220.53
- BOTOX (Biological) $213.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Houston
Dr. Alpesh Desai
Dermatology — Payments: $1.4M
Dermatology $1.4M
Dr. Michael Migden, Md, MD
Dermatology — Payments: $379,143
Dermatology $379,143
Dr. Geeta Patel, D.o, D.O
Dermatology — Payments: $341,210
Dermatology $341,210
Catherine Papasakelariou, M.d, M.D
Dermatology — Payments: $270,262
Dermatology $270,262
Megan Couvillion, Md, MD
Dermatology — Payments: $154,211
Dermatology $154,211
Suzanne Bruce, M.d, M.D
Dermatology — Payments: $135,195
Dermatology $135,195